Journal of Applied Physiology Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Appl Physiol 77: 121-126, 1994;
8750-7587/94 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ahlborg, G.
Right arrow Articles by Lundberg, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ahlborg, G.
Right arrow Articles by Lundberg, J. M.

Journal of Applied Physiology, Vol 77, Issue 1 121-126, Copyright © 1994 by American Physiological Society

ARTICLES

Endothelin-1 infusion reduces splanchnic glucose production in humans

G. Ahlborg, E. Weitzberg and J. M. Lundberg
Department of Clinical Physiology, Karolinska Hospital, Stockholm, Sweden.

Two groups of six healthy subjects received an intravenous endothelin-1 (ET-1) infusion (4 pmol.kg-1.min-1 for 20 min) in the basal state. Blood was drawn from catheters in an artery (n = 12), a hepatic vein (n = 12), and a renal vein (n = 6) for determinations of blood flows and substrate exchanges. During the ET-1 infusion, splanchnic and renal blood flows were reduced by approximately 50 (P < 0.01) and 25% (P < 0.001), respectively. Arterial glucose concentration and splanchnic glucose production fell by approximately 4 (P < 0.01) and 55% (P < 0.001), respectively. The latter was still 30% below basal level 3 h after the infusion (P < 0.001). Arterial glycerol increased by 64% (P < 0.01), whereas arterial lactate was unchanged. Splanchnic uptakes of lactate and glycerol were unchanged. Arterial insulin and glucagon showed transient falls with a maximal drop of approximately 35% (P < 0.001) during the infusion. In conclusion, ET-1 infusion causes reduced splanchnic glucose production due to reduced glycogen-derived glucose release. The latter could partly be connected with the transient fall in arterial glucagon, but the prolonged suppressive effect on splanchnic glycogenolysis seems to be linked with other ET-1-related factors. We propose that the underlying mechanism to the transient falls in both arterial glucagon and insulin might be coupled to the ET-1-arginine-NO system.


This article has been cited by other articles:


Home page
 Diabetes CareHome page
G. Ahlborg, A. Shemyakin, F. Bohm, A. Gonon, and J. Pernow
Dual Endothelin Receptor Blockade Acutely Improves Insulin Sensitivity in Obese Patients With Insulin Resistance and Coronary Artery Disease
Diabetes Care, March 1, 2007; 30(3): 591 - 596.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
G. Ahlborg and J. Lindstrom
Insulin sensitivity and big ET-1 conversion to ET-1 after ETA- or ETB-receptor blockade in humans
J Appl Physiol, December 1, 2002; 93(6): 2112 - 2121.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
G. Ahlborg and J. M. Lundberg
Cyclooxygenase inhibition potentiates the renal vascular response to endothelin-1 in humans
J Appl Physiol, November 1, 1998; 85(5): 1661 - 1666.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
G. Ahlborg and J. M. Lundberg
Nitric oxide-endothelin-1 interaction in humans
J Appl Physiol, May 1, 1997; 82(5): 1593 - 1600.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online